OR4A19P

Across TCGA pan-cancer cohorts, OR4A19P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR4A19P data layer.

The strongest signal is observed in thymoma (THYM), where higher OR4A19P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4A19P expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.

THYM, ESCA, and UCEC are the cancer types where OR4A19P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	36	view →
ESCA	OS	Tertile	III,IV	0.759	0.366	.023	30	view →
UCEC	DFS	Tertile	All	0.672	0.899	.002	30	view →
BRCA	OS	Tertile	II,III,IV	0.836	0.544	.016	24	view →
SARC	DFS	Tertile	All	0.202	0.524	.005	24	view →
COAD	OS	Tertile	III,IV	0.142	0.792	<.001	18	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
LAML	DFS	Tertile	All	0.028	0.583	.001	18	view →
HNSC	OS	Tertile	III,IV	0.289	0.678	.041	9	view →
LUAD	OS	Tertile	All	0.580	0.788	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR4A19P–THYM (DFS)

Open the THYM breakdown →